Literature DB >> 26944616

Synthesis of tetracyclic iminosugars fused benzo[e][1,3]thiazin-4-one and their HIV-RT inhibitory activity.

Zhuqing Yin1, Mo Zhu1, Sinan Wei1, Jie Shao1, Yuheng Hou1, Hua Chen2, Xiaoliu Li3.   

Abstract

Several aza-C-pseudonucleosides bearing 1,3-benzothiazin-4-one (6 and 7) were prepared by the one-pot three-component condensation from the iminosugar aldehyde 3, amino acid ethyl/methyl ester hydrochlorides 4(a-c), and 2-mercaptobenzoic acid 5. After removal of Boc and the isopropylidene groups, the target novel tetracyclic iminosugars fused benzo[e][1,3]thiazin-4-one 1(a-c) and 2(a-b) were first afforded by the intramolecular cyclo-amidation reaction. Their structures were determined by their (1)H, (13)C NMR, and HRMS (ESI) spectra and X-ray. The tetracyclic iminosugars 1(a-c) and 2(a-b) were examined for their HIV reverse transcriptase (RT) inhibitory activities. The result showed that all compounds could effectively inhibit RT activity. Among them, compound 2a was the best one with the IC50 value of RT inhibitory activity of 0.82μM. Structure-activity relationship analysis suggested that 1'R configuration in the tetracyclic azasugars was of benefit to their anti-HIV RT activity.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-HIV RT activity; Aza-C-pseudonucleoside; Benzo[e][1,3]thiazin-4-one; One-pot three-component reaction; Tetracyclic iminosugar

Mesh:

Substances:

Year:  2016        PMID: 26944616     DOI: 10.1016/j.bmcl.2016.02.049

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Crystal structures of two 2,3-diaryl-2,3-di-hydro-4H-1,3-benzo-thia-zin-4-ones.

Authors:  Hemant P Yennawar; Michaela J Buchwalter; Baylee K Colburn; Lee J Silverberg
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-02-20

2.  Evaluation of the effect of 2-(2,4-dihydroxyphenyl)-4H-benzofuro[3,2-d][1,3]thiazin-4-one on colon cells and its anticancer potential.

Authors:  Arkadiusz Czerwonka; Marta K Lemieszek; Monika Karpińska; Joanna Matysiak; Andrzej Niewiadomy; Wojciech Rzeski
Journal:  Med Chem Res       Date:  2018-07-25       Impact factor: 1.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.